These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7537655)

  • 1. Rethinking thalidomide.
    Environ Health Perspect; 1995 Feb; 103(2):132. PubMed ID: 7537655
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientists take aim at angiogenesis to treat degenerative eye diseases.
    Hampton T
    JAMA; 2004 Mar; 291(11):1309-10. PubMed ID: 15026379
    [No Abstract]   [Full Text] [Related]  

  • 3. Technology evaluation: pegaptanib, Eyetech/Pfizer.
    Vinores SA
    Curr Opin Mol Ther; 2003 Dec; 5(6):673-9. PubMed ID: 14755895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging therapies for ocular neovascularisation.
    Reynolds AL; Kent D; Kennedy BN
    Adv Exp Med Biol; 2014; 801():797-804. PubMed ID: 24664773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.
    Stahl A; Krohne TU; Sapieha P; Chen J; Hellstrom A; Chew E; Holz FG; Smith LE
    Br J Ophthalmol; 2011 Nov; 95(11):1496-501. PubMed ID: 21421650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eye and pathologic angiogenesis].
    Ishibashi T
    Fukuoka Igaku Zasshi; 2000 Nov; 91(11):277-83. PubMed ID: 11187718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Using thalidomide against pathological neovascularization].
    Eisenkraft A; Luria S; Robenshtok E; Hourvitz A
    Harefuah; 2003 Mar; 142(3):212-6, 237. PubMed ID: 12696477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering lipids in eye disease.
    Denniston A; Banerjee S
    Hosp Med; 2002 Dec; 63(12):753. PubMed ID: 12512205
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibiting angiogenesis in retinoblastoma.
    Apte RS; Harbour JW
    Ophthalmic Res; 2007; 39(4):188-90. PubMed ID: 17556838
    [No Abstract]   [Full Text] [Related]  

  • 10. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Favorable results of anabolic therapy in cases of retinal degeneration].
    Sobieska-Clarowa H
    Klin Oczna; 1975 Jul; 45(7):811-4. PubMed ID: 1160303
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy.
    Kwa FA; Thrimawithana TR
    Drug Discov Today; 2014 Sep; 19(9):1387-93. PubMed ID: 24717156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery methods for posterior segment disease.
    Hsu J
    Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The progress of treatment for diabetic maculopathy].
    Sakamoto T
    Nippon Ganka Gakkai Zasshi; 2008 May; 112(5):445-6. PubMed ID: 18517003
    [No Abstract]   [Full Text] [Related]  

  • 15. Deal watch: Alcon licenses complement pathway inhibitor for macular degeneration.
    Nat Rev Drug Discov; 2009 Dec; 8(12):922. PubMed ID: 19949394
    [No Abstract]   [Full Text] [Related]  

  • 16. [VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF].
    Wylegała E; Teper SJ
    Klin Oczna; 2007; 109(1-3):94-6. PubMed ID: 17687924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide: when everything old is new again.
    Nirenberg A
    Clin J Oncol Nurs; 2001; 5(1):15-8. PubMed ID: 11899395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal application of triamcinolone--our experiences].
    Konjević Pernar S; Vatavuk Z; Bencić G; Pentz A; Mandić Z
    Acta Med Croatica; 2006; 60(2):133-5. PubMed ID: 16848205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of thalidomide in the treatment of cancer].
    Bay JO; Tournilhac O
    Bull Cancer; 2000 Apr; 87(4):301-2. PubMed ID: 10858046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.